HOLX News and Press, Hologic Inc. From 02/27/24

Global Leader in Women’s Health to Present Research and Educational Opportunities Focused on Improving Workflow and Efficiency Hologic, Inc. (Nasdaq: HOLX) continues to deliver on its commitment to advancing women’s health by unveiling new research in artificial intelligen...

2024-02-11 10:54:53 ET Summary Hologic aims to elevate women's health globally, with diagnostics making up nearly half of sales. The company experienced a boom in COVID diagnostics sales in 2020 and 2021, creating headwinds thereafter, yet this is set to end in 2024. Amidst a ...

2024-02-06 13:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-02 07:04:51 ET The financials of the company show a decreasing trend in revenue growth due to lower spare parts sales and a decrease in service contracts. However, there was an increase in installation and training revenue. Operating expenses decreased due to various factors, but ther...

2024-02-02 05:57:43 ET Hologic ( NASDAQ: HOLX ) has received approval from the U.S. Food and Drug Administration (FDA) approval for its new digital cytology system, making it the first FDA-cleared digital cytology platform.... Read the full article on Seeking Alpha ...

2024-02-01 22:56:03 ET Hologic, Inc. (HOLX) Q1 2024 Earnings Conference Call February 1, 2024 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Steve MacMillan - Chairman, President and Chief Executive Officer Karleen Oberton - Chief...

Through a Combination of Advanced Imaging and Novel Artificial Intelligence, Latest Diagnostic System for Cervical Cancer Screening Can Help More Accurately Detect Disease, Improve Workflow and Enhance Patient Care Hologic, Inc. (Nasdaq: HOLX) announced today that its new GeniusȒ...

2024-02-01 16:02:29 ET More on Hologic Hologic: Navigating The Covid Cliff Hologic, Inc. (HOLX) Q4 2023 Earnings Call Transcript Hologic Q1 2024 Earnings Preview Hologic guides Q1 revenue above estimates Seeking Alpha’s Quant Rating on Hologic ...

– Revenue of $1,013.1 Million, GAAP Diluted EPS of $1.03, and Non-GAAP Diluted EPS of $0.98; All Exceed Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 5.2% in Constant Currency Against Four Fewer Selling Days Compared to the Prior Year Period ...

IDW Media Holdings, Inc. (IDWM) is expected to report for quarter end 2023-10-31 Deluxe Corporation (DLX) is expected to report $0.62 for Q4 2023 SkyWest Inc. (SKYW) is expected to report $0.11 for Q4 2023 1-800-FLOWERS.COM Inc. (FLWS) is expected to report $1.22 for Q2 2024 Brook...